|
| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Hematology
|
2014
|
NHLBI
|
5R44HL099192-03
|
|
Minimally Invasive Pediatric VAD for Treatment of Acute Heart Failure
|
CORBETT, SCOTT
|
ABIOMED, INC.
|
MA
|
$428,642
|
|
Hematology
|
2014
|
NIDDK
|
5K23DK084115-05
|
|
Investigations into the Glutamine-Citruline-Arginine Pathway in Sepsis
|
KAO, CHRISTINA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$171,885
|
|
Hematology
|
2014
|
NIGMS
|
1R01GM106314-01
|
|
PKR mediated inflammasome activation and pyroptosis in sepsis
|
TRACEY, KEVIN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$320,150
|
|
Hematology
|
2014
|
NCI
|
5R01CA163394-02
|
|
Impact of chlorhexidine bathing on reducing infections in children with cancer
|
ZERR, DANIELLE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$353,172
|
|
Hematology
|
2014
|
NIEHS
|
5R01ES004862-20
|
|
Ah Receptor Dysregulation Alters Hematopoietic Stem Cells
|
GASIEWICZ, THOMAS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$366,763
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106145-04
|
|
In vivo mechanism of mimetic peptide effects on atherosclerosis and inflammation
|
REARDON-ALULIS, CATHERINE
|
UNIVERSITY OF CHICAGO
|
IL
|
$382,200
|
|
Hematology
|
2014
|
NIAAA
|
5P60AA009803-21
|
5162
|
Research Component 4
|
ZHANG, PING
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$109,509
|
|
Hematology
|
2014
|
NHLBI
|
2R01HL077671-09
|
|
Endothelial Toll-Like Receptor Signaling and Inflammation
|
LI, DEAN
|
UNIVERSITY OF UTAH
|
UT
|
$372,500
|
|
Hematology
|
2014
|
NIEHS
|
5R01ES020875-03
|
|
De novo CNV formation in vivo with sickle cell anemia therapy
|
GLOVER, THOMAS
|
UNIVERSITY OF MICHIGAN
|
MI
|
$379,559
|
|
Hematology
|
2014
|
NIAID
|
5R01AI056234-11
|
|
Genetic analysis of inflammatory responses in wild-derived mice
|
POLTORAK, ALEXANDER
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$412,500
|
|
Hematology
|
2014
|
NEI
|
5R21EY022466-02
|
|
New Models of Endogenous Bacterial Endophthalmitis
|
CALLEGAN, MICHELLE
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$217,560
|
|
Hematology
|
2014
|
NIAID
|
5R01AI097320-02
|
|
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
|
PORTEUS, MATTHEW
|
STANFORD UNIVERSITY
|
CA
|
$390,344
|
|
Hematology
|
2014
|
NIAID
|
5R01AI083453-05
|
|
The NF-kB signaling system as a regulator of B-cell activation
|
HOFFMANN, ALEXANDER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$40,878
|
|
Hematology
|
2014
|
NIDDK
|
5R01DK073462-08
|
|
IRON LIPOCALIN NGAL IN KIDNEY DISEASE
|
BARASCH, JONATHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$348,000
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL110907-03
|
|
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
|
LUZNIK, LEO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$412,570
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM053522-15
|
|
Amelioration of Sepsis by Macrophage Activation
|
WILLIAMS, DAVID
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$287,077
|
|
Hematology
|
2014
|
NIAID
|
5R01AI093737-03
|
|
Role of the developmental regulator Gon4-like in B lymphopoiesis
|
COLGAN, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$377,500
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL060772-14
|
|
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$372,400
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL077258-07
|
|
Von Willebrand Factor structure and function under fluid flow
|
NEELAMEGHAM, SRIRAM
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$380,221
|
|
Hematology
|
2014
|
NCI
|
5R01CA083962-15
|
|
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
MO
|
$376,310
|
|
Hematology
|
2014
|
NCI
|
5R01CA085180-13
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$680,363
|
|
Hematology
|
2014
|
NCI
|
5R01CA100225-09
|
|
Self-renewal of Normal and Leukemic Stem Cells
|
CLARKE, MICHAEL
|
STANFORD UNIVERSITY
|
CA
|
$282,911
|
|
Hematology
|
2014
|
NCI
|
5R01CA105312-09
|
|
MOLECULAR STUDIES OF BONE MARROW FAILURE
|
BESSLER, MONICA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$561,426
|
|
Hematology
|
2014
|
NCI
|
5R01CA128800-05
|
|
Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
|
LEMASSON, ISABELLE
|
EAST CAROLINA UNIVERSITY
|
NC
|
$250,365
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106074-04
|
|
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
|
THOMAS, WENDY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$410,844
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL112603-03
|
|
Hemostatic factors and sickle cell disease
|
DEGEN, JAY
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$374,850
|
|
Hematology
|
2014
|
NCI
|
5R01CA158006-03
|
|
Ikaros-based epigenetic regulation of T cell leukemogenesis
|
GEORGOPOULOS, KATIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$331,951
|
|
Hematology
|
2014
|
NCI
|
5R01CA089455-13
|
|
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer
|
SHILATIFARD, ALI
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH
|
MO
|
$248,605
|
|
Hematology
|
2014
|
NCI
|
5R01CA134674-05
|
|
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
|
CAMP, NICOLA
|
UNIVERSITY OF UTAH
|
UT
|
$509,782
|
|
Hematology
|
2014
|
NCI
|
5R01CA155223-04
|
|
Mechanisms of Epigenetic Gene Silencing
|
PRUITT, KEVIN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
LA
|
$260,853
|
|
Hematology
|
2014
|
NIDDK
|
5R37DK039949-32
|
|
Genomic and Translational Approaches to Neuroendocrine Switching Events
|
ROSENFELD, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$618,436
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL104165-04
|
|
Structure-function of cytoprotective coagulation proteases and their receptors
|
MOSNIER, LAURENT
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$464,275
|
|
Hematology
|
2014
|
NHLBI
|
5SC1HL104638-05
|
|
Genetic and Epigenetic Regulation of Hematopoiesis.
|
SALEQUE, SHIREEN
|
CITY COLLEGE OF NEW YORK
|
NY
|
$377,300
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106184-04
|
|
Barrier Insulators in Erythropoiesis
|
GALLAGHER, PATRICK
|
YALE UNIVERSITY
|
CT
|
$407,925
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL112597-03
|
|
MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA
|
AGRAWAL, DEVENDRA
|
CREIGHTON UNIVERSITY
|
NE
|
$779,682
|
|
Hematology
|
2014
|
NCI
|
5R01CA102142-10
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$321,009
|
|
Hematology
|
2014
|
NCI
|
5R01CA151949-05
|
|
Molecular Pathogenesis and Therapy of ET and PMF
|
LEVINE, ROSS
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$419,296
|
|
Hematology
|
2014
|
NIAID
|
5R01AI098369-03
|
|
Function of Vibrio vulnificus MARTX toxin during early gut infection
|
SATCHELL, KARLA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$253,327
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106018-04
|
|
Site-Specific Therapies To Prevent Intimal Hyperplasia
|
CHAIKOF, ELLIOT
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$390,040
|
|
Hematology
|
2014
|
NHLBI
|
5K25HL107617-03
|
|
Improved stent design through hemodynamics and vascular biology
|
JIMENEZ, JUAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$146,750
|
|
Hematology
|
2014
|
NIAID
|
5R01AI051390-13
|
|
Immunology of factor IX gene transfer to liver
|
HERZOG, ROLAND
|
UNIVERSITY OF FLORIDA
|
FL
|
$336,188
|
|
Hematology
|
2014
|
NCI
|
5R01CA117830-09
|
|
Regulation of KSHV Latency
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
PA
|
$309,287
|
|
Hematology
|
2014
|
NCI
|
5R01CA139319-05
|
|
The ARF Tumor Suppressor
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
PA
|
$361,188
|
|
Hematology
|
2014
|
NCI
|
5R01CA102184-09
|
|
Functional Analysis of p53 Polymorphic Variants
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
PA
|
$335,745
|
|
Hematology
|
2014
|
NCI
|
5R01CA105129-09
|
|
Regulation of hematopoietic stem cell differentiation
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$290,603
|
|
Hematology
|
2014
|
NCI
|
5R01CA139633-05
|
|
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$559,582
|
|
Hematology
|
2014
|
NINDS
|
5R01NS062792-06
|
|
The Mucolipin TRP Ion Channels
|
XU, HAOXING
|
UNIVERSITY OF MICHIGAN
|
MI
|
$323,354
|
|
Hematology
|
2014
|
NCI
|
5R01CA149976-04
|
|
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
|
SPECK, NANCY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$322,040
|
|
Hematology
|
2014
|
NIDCR
|
5R01DE022820-02
|
|
Real-Time Flap Viability Monitoring during Facial Transplantation using SFDI
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$614,064
|
|
Hematology
|
2014
|
NIDDK
|
5R00DK087923-05
|
|
Genetic correction of human beta-thalassemic induced pluripotent stem cells
|
PAPAPETROU, EIRINI
|
UNIVERSITY OF WASHINGTON
|
WA
|
$249,000
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM057692-15
|
|
Structural studies of a spectrin/ankyrin complex
|
MONDRAGON, ALFONSO
|
NORTHWESTERN UNIVERSITY
|
IL
|
$276,846
|
|
Hematology
|
2014
|
NCI
|
5R01CA155743-04
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$322,040
|
|
Hematology
|
2014
|
NIAID
|
5R01AI098078-03
|
|
Pathogenesis of Salmonella bacteremia
|
TSOLIS, RENEE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$365,791
|
|
Hematology
|
2014
|
NCI
|
5R01CA072669-17
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
BLAZAR, BRUCE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$285,254
|
|
Hematology
|
2014
|
NCI
|
5R01CA137116-04
|
|
Role of the Bone Marrow Microenvironment in the Development of Multiple Myeloma
|
EDWARDS, CLAIRE
|
UNIVERSITY OF OXFORD
|
UK
|
$210,856
|
|
Hematology
|
2014
|
NCI
|
5R01CA140515-05
|
|
Tyrosine Kinase Signaling in Cancer Cell Metabolism
|
CHEN, JING
|
EMORY UNIVERSITY
|
GA
|
$305,027
|
|
Hematology
|
2014
|
NHLBI
|
5R24HL085794-08
|
|
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
|
TARANTAL, ALICE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$1,000,546
|
|
Hematology
|
2014
|
NIAID
|
5R24HL085794-08
|
|
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
|
TARANTAL, ALICE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$10,000
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL107127-04
|
|
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
|
KERR, WILLIAM
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$399,982
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL111103-03
|
|
Identification and characterization of genes in del(5q) myelodysplastic syndrome
|
STARCZYNOWSKI, DANIEL
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$374,850
|
|
Hematology
|
2014
|
NCI
|
5R01CA138891-05
|
|
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
|
PAULSON, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$365,448
|
|
Hematology
|
2014
|
NCI
|
5R01CA142809-05
|
|
Signal Transduction Pathways in CD30-positive Lymphomas
|
DUCKETT, COLIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$300,886
|
|
Hematology
|
2014
|
NINDS
|
5F32NS082005-02
|
|
The role of PI3K/Akt pathway in the pathogenesis and treatment of Krabbe disease
|
FEHR, TUBA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$58,946
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM040586-25
|
|
Cytokine Regulation in Sepsis/Inflammation
|
MOLDAWER, LYLE
|
UNIVERSITY OF FLORIDA
|
FL
|
$302,569
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL064274-13
|
|
Hepatic Gene Transfer for Treatment of Hemophilias A & B
|
KAY, MARK
|
STANFORD UNIVERSITY
|
CA
|
$536,089
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL095896-05
|
|
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation
|
ZHANG, JIWANG
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$362,612
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL103827-03
|
|
O-fucose Modified Notch as a Regulator of the Hematopoietic Stem Cell Homeostasis
|
ZHOU, LAN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$384,650
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL096305-05
|
|
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
|
PELUS, LOUIS
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$373,527
|
|
Hematology
|
2014
|
NIAID
|
5K23AI091623-04
|
|
Phase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent GVHD
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
MI
|
$132,300
|
|
Hematology
|
2014
|
NCI
|
5R01CA095318-10
|
|
Role of B Cells in Murine Gammaherpesvirus-68 Latency
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
GA
|
$320,872
|
|
Hematology
|
2014
|
NCI
|
5R01CA104588-10
|
|
RAG-induced DNA damage: mechanisms and responses
|
ROTH, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$266,568
|
|
Hematology
|
2014
|
NCI
|
5R01CA138720-05
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$343,617
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL085107-07
|
|
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors
|
RUSSELL, DAVID
|
UNIVERSITY OF WASHINGTON
|
WA
|
$654,926
|
|
Hematology
|
2014
|
NCI
|
5R01CA080320-15
|
|
Myc Oncogene Mutations and Polymorphisms in Cancer
|
COLE, MICHAEL
|
DARTMOUTH COLLEGE
|
NH
|
$326,672
|
|
Hematology
|
2014
|
NCI
|
5P30CA016520-38
|
5516
|
Tumor Virology Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$115,256
|
|
Hematology
|
2014
|
NCI
|
5P30CA016520-38
|
5520
|
Melanoma and Cutaneous Malignancies Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$115,856
|
|
Hematology
|
2014
|
NCI
|
5P30CA016520-38
|
5521
|
Hematologic Malignancies Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$135,765
|
|
Hematology
|
2014
|
NCI
|
5P30CA016086-38
|
8689
|
Virology
|
TRAUB, N
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$133,482
|
|
Hematology
|
2014
|
NCI
|
5P30CA016086-38
|
8690
|
Virology
|
TRAUB, N
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$142,314
|
|
Hematology
|
2014
|
NCI
|
5R01CA138747-05
|
|
microRNA-155 and Lymphoma
|
AGUIAR, RICARDO
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$289,927
|
|
Hematology
|
2014
|
NCI
|
5R21CA161666-02
|
|
Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia
|
GILBERT, DAVID
|
FLORIDA STATE UNIVERSITY
|
FL
|
$95,744
|
|
Hematology
|
2014
|
NCI
|
5R01CA172106-02
|
|
Delta-like ligand 4+ dendritic cells and induction of alloimmunity
|
ZHANG, YI
|
UNIVERSITY OF MICHIGAN
|
MI
|
$7,282
|
|
Hematology
|
2014
|
NIDDK
|
5R01DK052962-11
|
|
Novel Globin Gene Modulators
|
PERRINE, SUSAN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$356,048
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL107608-03
|
|
Role of RBC NO and ATP in Sickle Vasculopathy
|
TELEN, MARILYN
|
DUKE UNIVERSITY
|
NC
|
$384,650
|
|
Hematology
|
2014
|
NCI
|
5R01CA138398-06
|
|
C-reactive protein promotes myeloma cell-mediated bone destruction
|
YI, QING
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$348,132
|
|
Hematology
|
2014
|
NCI
|
5R01CA142798-05
|
|
The contribution of protein translation to tumorigenesis
|
WENDEL, HANS-GUIDO
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$370,951
|
|
Hematology
|
2014
|
NCI
|
5R01CA150265-05
|
|
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
|
SHILATIFARD, ALI
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH
|
MO
|
$347,572
|
|
Hematology
|
2014
|
NCI
|
5R01CA152101-05
|
|
Targeting Somatic Homologous Recombination in Solid Tumors
|
VILLALONA, MIGUEL
|
OHIO STATE UNIVERSITY
|
OH
|
$489,114
|
|
Hematology
|
2014
|
NCI
|
5R21CA171937-02
|
|
Inhibitory targeting of HHV-8 vIL-6-related interactions.
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$205,068
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL068130-13
|
|
Cytoskeletal Mechanisms of Platelet Formation
|
ITALIANO, JOSEPH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$428,861
|
|
Hematology
|
2014
|
NHLBI
|
1R13HL120495-01
|
|
New Frontiers in the Discovery and Treatment of Thrombosis
|
WOODLAND, DAVID
|
KEYSTONE SYMPOSIA
|
CO
|
$7,453
|
|
Hematology
|
2014
|
NCI
|
5R01CA139872-05
|
|
Synstatin Therapy for Multiple Myeloma
|
RAPRAEGER, ALAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$377,380
|
|
Hematology
|
2014
|
NCI
|
5R01CA157537-04
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$307,951
|
|
Hematology
|
2014
|
NCI
|
5R01CA114536-10
|
|
Strategies to improve the adoptive transfer of T cells
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$448,945
|
|
Hematology
|
2014
|
NCI
|
5R01CA134794-05
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$281,660
|
|
Hematology
|
2014
|
NCI
|
5R01CA142665-05
|
|
Glucocorticoids in Lymphoblastic Leukemia
|
RELLING, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$377,484
|
|
Hematology
|
2014
|
NCI
|
5R01CA154739-03
|
|
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics
|
CLEVELAND, JOHN
|
SCRIPPS FLORIDA
|
FL
|
$747,603
|
|
Hematology
|
2014
|
NCI
|
5R01CA148950-04
|
|
Regulation of Myc-Mediated Tumorigenesis
|
EISCHEN, CHRISTINE
|
VANDERBILT UNIVERSITY
|
TN
|
$313,718
|
|
Hematology
|
2014
|
NCI
|
5R01CA047988-23
|
|
Women's Health Study: Continued Follow-up
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,780,348
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM100481-03
|
|
Neonatal hyperbilirubinemia in a humanized UGT1 animal model
|
TUKEY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$322,729
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM079641-07
|
|
Function of PHD Domain Proteins in Chromatin Regulation
|
GOZANI, OR
|
STANFORD UNIVERSITY
|
CA
|
$314,000
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM100913-02
|
|
Neutrophil-derived microparticle generation and immune impact during sepsis
|
CALDWELL, CHARLES
|
UNIVERSITY OF CINCINNATI
|
OH
|
$301,150
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL095676-05
|
|
Regulation of Platelet Glycoprotein (GP) Ib-IX Complex Function by Membrane Lipid
|
PENG, YUANDONG
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$293,945
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL097971-05
|
|
Model of Platelet Adhesion and Thrombus Formation
|
KING, MICHAEL
|
CORNELL UNIVERSITY
|
NY
|
$395,048
|
|
Hematology
|
2014
|
NCI
|
5R01CA133881-05
|
|
Genetic Predictors of AML Treatment Response
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$455,264
|
|
Hematology
|
2014
|
NCI
|
5R01CA142874-05
|
|
Targeting PML for leukemia therapy.
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$436,776
|
|
Hematology
|
2014
|
NCI
|
5R01CA167289-02
|
|
Mechanism of action of Prdm16 in hematopoietic stem cells
|
SNOECK, HANS-WILLEM
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$322,040
|
|
Hematology
|
2014
|
NIDDK
|
5K08DK085152-06
|
|
Elucidation of Novel Anti-apoptotic Pathways in Erythropoiesis
|
WANG, YONGPING
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$150,540
|
|
Hematology
|
2014
|
NIDDK
|
5K01DK087814-04
|
|
Zebrafish Stem and Progenitor Cells and their Dysregulation in Leukemogenesis
|
STACHURA, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$161,228
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM098956-04
|
|
Ras18-mediated Fanconi Anemia pathway activation in response to camptothecin
|
PALLE, KOMARAIAH
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$228,690
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL095511-05
|
|
TCD with Transfusions Changing to Hydroxyurea - SDMC
|
DAVIS, BARRY
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$674,232
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL105809-04
|
|
Caring for Those Who Share: Mitigating Iron Deficiency in Regular Blood Donors
|
MAST, ALAN
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$775,840
|
|
Hematology
|
2014
|
NCI
|
5R01CA138744-05
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$327,998
|
|
Hematology
|
2014
|
NCI
|
5R01CA142620-05
|
|
Immunologic targets in Myeloid Leukemia
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$320,189
|
|
Hematology
|
2014
|
NCI
|
5R01CA155056-04
|
|
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
|
KONOPLEVA, MARINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$317,049
|
|
Hematology
|
2014
|
NIDDK
|
5R01DK089174-04
|
|
Comparative Epidemiology for Emerging Glycemic Markers
|
SELVIN, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$591,068
|
|
Hematology
|
2014
|
NIEHS
|
5R01ES010807-14
|
|
Molecular Mechanisms of Complex Mixture Toxicity
|
PUGA, ALVARO
|
UNIVERSITY OF CINCINNATI
|
OH
|
$447,496
|
|
Hematology
|
2014
|
NICHD
|
5U01HD049934-10
|
|
Data Coordinating Center for the Collaborative Pediatric Critical Care
|
DEAN, JONATHAN
|
UNIVERSITY OF UTAH
|
UT
|
$2,674,407
|
|
Hematology
|
2014
|
NICHD
|
5U10HD049983-10
|
|
Collaborative Pediatric Critical Care Research Network At Children's Hospital of
|
CARCILLO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$259,558
|
|
Hematology
|
2014
|
NCI
|
5R01CA142664-05
|
|
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
|
YOTNDA, PATRICIA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$299,690
|
|
Hematology
|
2014
|
NCI
|
7R01CA172070-02
|
|
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
|
HOLSTEIN, SARAH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$341,343
|
|
Hematology
|
2014
|
NCI
|
5R01CA172492-02
|
|
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma
|
PASQUALUCCI, LAURA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$322,040
|
|
Hematology
|
2014
|
NCI
|
5R01CA166450-02
|
|
Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia
|
RAO, DINESH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$309,964
|
|
Hematology
|
2014
|
NCI
|
5R03CA167752-02
|
|
Alternative Cleavage and Polyadenylation Events as Biomarkers
|
WAGNER, ERIC
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$73,720
|
|
Hematology
|
2014
|
NIDA
|
5R03DA035086-02
|
|
Platelet activation by cocaine in HIV-1 patients involves IKK
|
KIEBALA, MICHELLE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$76,750
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL013423-41
|
|
Plasminogen and Plasmin: Structure and Function
|
CASTELLINO, FRANCIS
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$385,235
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL081326-07
|
|
Factor XI in Thrombosis
|
GAILANI, DAVID
|
VANDERBILT UNIVERSITY
|
TN
|
$381,416
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL088511-05
|
|
Respect, Trust, and Patient Outcomes in Sickle Cell Disease
|
BEACH, MARY CATHERINE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$772,222
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL107483-03
|
|
Factor VIIa Interaction with Endothelial Cell Protein C Receptor
|
LELLA, VIJAYA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$345,450
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL111372-03
|
|
PlGF-HIF1a-miRNA Axis in Sickle Pulmonary Hypertension
|
KALRA, VIJAY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$604,586
|
|
Hematology
|
2014
|
NCI
|
5R37CA084628-22
|
|
Telomerase in Development, Senescence and Neoplasia
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$600,026
|
|
Hematology
|
2014
|
NCI
|
5R01CA138535-05
|
|
Novel Heparanase Inhibitors for Cancer Therapy
|
SANDERSON, RALPH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$352,380
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL111659-03
|
|
Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy
|
ATAGA, KENNETH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$450,555
|
|
Hematology
|
2014
|
NIAID
|
5R01AI100987-02
|
|
Manipulation of inflammasomes and NF-kB signaling in human myeloid cells by Myxom
|
MCFADDEN, GRANT
|
UNIVERSITY OF FLORIDA
|
FL
|
$373,750
|
|
Hematology
|
2014
|
NIGMS
|
5R01GM060475-11
|
|
Neutrophil activation and trauma
|
JUNGER, WOLFGANG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$508,950
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL082808-09
|
|
Structure and Function of Platelet Glycoprotein Ib-IX-V Complex
|
LI, RENHAO
|
EMORY UNIVERSITY
|
GA
|
$373,176
|
|
Hematology
|
2014
|
NIGMS
|
5K23GM104022-02
|
|
Pre-hospital identification of high-risk sepsis
|
SEYMOUR, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$187,040
|
|
Hematology
|
2014
|
NCI
|
5R01CA172582-02
|
|
Alpha Radioimmunotherapy for Lymphoma Treatment
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$640,365
|
|
Hematology
|
2014
|
NICHD
|
5K23HD070972-02
|
|
Postpartum Hemmorrhage and Anemia: Epidemiologic and Cost-Effectiveness Analyses
|
BUTWICK, ALEXANDER
|
STANFORD UNIVERSITY
|
CA
|
$132,624
|
|
Hematology
|
2014
|
NIAID
|
5R00AI099153-03
|
|
Regulation of EBV Latency by Chromosome Conformation
|
TEMPERA, ITALO
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$249,000
|
|
Hematology
|
2014
|
NCI
|
5R01CA164178-02
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
NH
|
$326,066
|
|
Hematology
|
2014
|
NCI
|
5R21CA168491-02
|
|
Targeting DEPTOR in multiple myeloma
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
CA
|
$168,780
|
|
Hematology
|
2014
|
NICHD
|
5U10HD063106-05
|
|
Collaborative Pediatric Research Critical Care Network(U10)
|
SHANLEY, THOMAS
|
UNIVERSITY OF MICHIGAN
|
MI
|
$256,590
|
|
Hematology
|
2014
|
NCI
|
5R01CA155294-04
|
|
Genetic Therapy for Fanconi Anemia
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$309,964
|
|
Hematology
|
2014
|
NIAID
|
5R01AI106393-02
|
|
BH3-only protein targeting by HHV-8
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
|
Hematology
|
2014
|
NCI
|
5P30CA006516-49
|
6045
|
Leukemia
|
LOOK, A
|
DANA-FARBER CANCER INST
|
MA
|
$276,222
|
|
Hematology
|
2014
|
NCI
|
5P30CA006516-49
|
6047
|
Lymphoma and Myeloma
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
MA
|
$88,354
|
|
Hematology
|
2014
|
NCI
|
5P30CA006516-49
|
6074
|
Cell Manipulation
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
MA
|
$309,200
|
|
Hematology
|
2014
|
NCI
|
5R01CA143032-05
|
|
Molecular Targeting of Diffuse Large B-cell Lymphoma
|
MELNICK, ARI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$502,192
|
|
Hematology
|
2014
|
NCI
|
5R01CA165206-03
|
|
CD19 Directed CAR Therapy
|
JUNE, CARL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$489,347
|
|
Hematology
|
2014
|
NICHD
|
5R01HD062484-04
|
|
Pharmacogenetic Determinants of Vincristine Toxicity and Response
|
RENBARGER, JAMIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$485,538
|
|
Hematology
|
2014
|
NCI
|
5P30CA016058-38
|
5566
|
Leukemia Tissue Bank
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
OH
|
$45,042
|
|
Hematology
|
2014
|
NCI
|
5P30CA014236-40
|
6411
|
Hematopoietic Cell Transplantation and Hematologice Malignancies
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
NC
|
$49,597
|
|
Hematology
|
2014
|
NCI
|
5P30CA014236-40
|
6438
|
Pharmaceutical Research
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
NC
|
$144,388
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL105613-05
|
|
Platelet Transfusion Induced Transplant Rejection Across mHA barriers.
|
ZIMRING, JAMES
|
PUGET SOUND BLOOD CENTER
|
WA
|
$458,150
|
|
Hematology
|
2014
|
NIAID
|
5R01AI083663-05
|
|
Mucosal barrier function during Salmonella infection
|
RAFFATELLU, MANUELA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$365,933
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL079669-09
|
|
Cell Priming, Receptor Cross-talk and Acute Lung Injury
|
FAN, JIE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$308,210
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL098174-05
|
|
Septic Lung Injury and Surfactant
|
MALLAMPALLI, RAMA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$330,717
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL109568-02
|
|
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
|
RAO, ANGARA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$376,397
|
|
Hematology
|
2014
|
NINDS
|
5R01NS057670-05
|
|
The regulation of myeloid cell development and mobilization during autoimmune dem
|
SEGAL, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$252,626
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL042493-20
|
|
Annexin A2 and Protein p11 in Endotoxemia and Sepsis
|
HAJJAR, KATHERINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$414,050
|
|
Hematology
|
2014
|
NHLBI
|
7R01HL079904-16
|
|
Heme Oxygenase-1/Carbon Monoxide in sepsis
|
CHOI, MARY
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$78,251
|
|
Hematology
|
2014
|
NCI
|
5R01CA138541-05
|
|
Myxoma Virus (MV) Oncolysis for treating human cancer
|
MCFADDEN, GRANT
|
UNIVERSITY OF FLORIDA
|
FL
|
$286,022
|
|
Hematology
|
2014
|
NIAID
|
5R01AI094642-03
|
|
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
|
ENGEL, JAMES
|
UNIVERSITY OF MICHIGAN
|
MI
|
$387,412
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL031823-25
|
|
Hematological consequences of FLVCR, a cytoplasmic heme export protein
|
ABKOWITZ, JANIS
|
UNIVERSITY OF WASHINGTON
|
WA
|
$382,200
|
|
Hematology
|
2014
|
NIMH
|
5R01MH085849-05
|
|
Risk for Psychopathology and Neurocognitive Impairment in Leukemia Survivors
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$490,478
|
|
Hematology
|
2014
|
NIBIB
|
5R01EB013297-03
|
|
MULTILAYER VASCULAR GRAFTS BASED ON COLLAGEN-MIMETIC HYDROGELS
|
COSGRIFF-HERNANDEZ, ELIZABETH
|
TEXAS ENGINEERING EXPERIMENT STATION
|
TX
|
$303,856
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL113574-02
|
|
Metabolites, Sickle Cell Disease, and Novel Therapeutics
|
XIA, YANG
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$372,400
|
|
Hematology
|
2014
|
NHLBI
|
5R21HL114237-03
|
|
Effect of non genetic factors on genetic signatures of complex traits
|
SEBASTIANI, PAOLA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$160,426
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL116452-02
|
|
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
MA
|
$425,929
|
|
Hematology
|
2014
|
NIAID
|
5R44AI092904-03
|
|
Rapidly boosting innate immunity in the lungs to protect against pneumonia
|
SCOTT, BRENTON
|
PULMOTECT, INC
|
TX
|
$308,146
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL057619-17
|
|
Gene Replacement Therapy for Sickle Cell Disease
|
TOWNES, TIM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$422,422
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL079571-10
|
|
A Vital Tool for the Study of DBA:The Diamond Blackfan Anemia Registry
|
LIPTON, JEFFREY
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$402,633
|
|
Hematology
|
2014
|
NHLBI
|
7R01HL095791-05
|
|
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
|
KEAN, LESLIE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$781,408
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL105631-04
|
|
Role of Fanconi Anemia Core Complex in the Incision of DNA Interstrand Crosslinks
|
ZHANG, YANBIN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$372,631
|
|
Hematology
|
2014
|
NIAAA
|
5K23AA019966-03
|
|
Circadian Desynchrony in Alcohol Induced Gut Leakiness
|
SWANSON, GARTH
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$171,555
|
|
Hematology
|
2014
|
NIAID
|
5R01AI093727-04
|
|
Role of the Plasminogen Activator Protease during Pneumonic Plague
|
LATHEM, WYNDHAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$381,250
|
|
Hematology
|
2014
|
NIAID
|
5R21AI105747-03
|
|
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
|
DENZIN, LISA
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$238,500
|
|
Hematology
|
2014
|
NIAID
|
5R21AI106013-02
|
|
Mechanism for copper-deficiency mediated neutropenia
|
THIELE, DENNIS
|
DUKE UNIVERSITY
|
NC
|
$235,500
|
|
Hematology
|
2014
|
NCI
|
5R01CA167708-02
|
|
Targeting AML with PI3K/AKT inhibitors and BH3-mimetics
|
GRANT, STEVEN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$276,250
|
|
Hematology
|
2014
|
NINDS
|
5U01NS079077-02
|
|
Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT)
|
GENTILE, NINA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$479,413
|
|
Hematology
|
2014
|
NCI
|
1U10CA180816-01
|
|
Stanford University NCTN- Network Lead Academic Site
|
WAKELEE, HEATHER
|
STANFORD UNIVERSITY
|
CA
|
$576,471
|
|
Hematology
|
2014
|
NIBIB
|
5R21EB015163-02
|
|
Development of Theranostic Ultrasound
|
PORTER, THOMAS
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$145,985
|
|
Hematology
|
2014
|
NCI
|
1U10CA180821-01
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$10,540,919
|
|
Hematology
|
2014
|
NCI
|
1U10CA180886-01
|
|
COG NCTN Network Group Operations Center
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$26,616,497
|
|
Hematology
|
2014
|
NCI
|
1U10CA180827-01
|
|
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
|
PAIETTA, ELISABETH
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
NY
|
$599,999
|
|
Hematology
|
2014
|
NCI
|
1U10CA180850-01
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
GOLDBERG, RICHARD
|
OHIO STATE UNIVERSITY
|
OH
|
$1,455,849
|
|
Hematology
|
2014
|
NCI
|
1U10CA180861-01
|
|
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
OH
|
$700,000
|
|
Hematology
|
2014
|
NCI
|
1U10CA180833-01
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
MO
|
$1,548,433
|
|
Hematology
|
2014
|
NIAID
|
5R21AI101750-02
|
|
Acinetobacter virulence and host innunopathogenesis
|
SPELLBERG, BRAD
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$204,763
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL081613-07
|
|
Serine/Threonine Phosphatases and Platelet Physiology
|
VIJAYAN, K. VINOD
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$383,425
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL111969-03
|
|
Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell Disease
|
LINDEN, JOEL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$788,408
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL112809-02
|
|
Platelet granule exocytosis and thrombus formation
|
FLAUMENHAFT, ROBERT
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$426,300
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL112836-02
|
|
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome
|
BEHRENS, EDWARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$414,256
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL113188-02
|
|
Ask1 a novel regulator of platelet function
|
NAIK, ULHAS
|
UNIVERSITY OF DELAWARE
|
DE
|
$374,850
|
|
Hematology
|
2014
|
NHLBI
|
5R21HL113895-02
|
|
4D Magnetic Resonance Imaging for Atrial Flow Assessment in Atrial Fibrillation
|
GOLDBERGER, JEFFREY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$216,213
|
|
Hematology
|
2014
|
NIAID
|
5K08AI093673-04
|
|
Role of Spi-C in eosinophil development and functional responses
|
FULKERSON, PATRICIA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$91,932
|
|
Hematology
|
2014
|
NIAID
|
5R21AI103851-02
|
|
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$226,500
|
|
Hematology
|
2014
|
NCI
|
5P01CA097175-10
|
7177
|
Functional links between Fanconi anemia proteins and interstrand crosslinks
|
LI, LEI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$153,444
|
|
Hematology
|
2014
|
NCI
|
5R01CA149566-04
|
|
Stem Cells, Differentiation and Therapeutic Resistance in AML
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$575,611
|
|
Hematology
|
2014
|
NCI
|
5R01CA153347-10
|
|
Molecular Mechanisms of the Hypoxic Response
|
LEE, FRANK
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$251,729
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL116472-02
|
|
Regulation of Innate Immunity by F-Box Proteins
|
CHEN, BEIBEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$375,769
|
|
Hematology
|
2014
|
NINDS
|
5R01NS073595-03
|
|
Mechanisms of Brain Injury after Intraventricular Hemorrhage
|
XI, GUOHUA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$336,755
|
|
Hematology
|
2014
|
NCI
|
5R01CA138816-05
|
|
HES1 mediates cell-specific consequences of Notch signaling in ALL
|
ZWEIDLER-MCKAY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$300,665
|
|
Hematology
|
2014
|
NCI
|
5R01CA149442-05
|
|
Novel selective small-molecule inhibitors of Mcl-1 protein
|
NIKOLOVSKA-COLESKA, ZANETA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$300,858
|
|
Hematology
|
2014
|
NCI
|
5R01CA158073-04
|
|
The Role of ATM in Suppression of Lymphomas
|
ZHA, SHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$322,040
|
|
Hematology
|
2014
|
NCI
|
5R37CA072614-18
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$295,630
|
|
Hematology
|
2014
|
NCI
|
5R01CA155226-04
|
|
Targeting the heat shock response for the therapy of DLBCL
|
MELNICK, ARI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$481,623
|
|
Hematology
|
2014
|
NCI
|
5R01CA168482-02
|
|
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$309,964
|
|
Hematology
|
2014
|
NCI
|
5R21CA173028-02
|
|
Impact of B-Cell Lineage on Progression of B-Acute Lymphoblastic Leukemia
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$197,209
|
|
Hematology
|
2014
|
NHLBI
|
5R21HL113490-02
|
|
Deformability distributions in heterogeneous red blood cell populations
|
KUYPERS, FRANS
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$200,288
|
|
Hematology
|
2014
|
NINDS
|
5R21NS070202-02
|
|
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
|
COSTA-MALLEN, PAOLA
|
BASTYR UNIVERSITY
|
WA
|
$191,648
|
|
Hematology
|
2014
|
NIAID
|
5U01AI104342-02
|
|
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
|
ESQUIVEL, CARLOS
|
STANFORD UNIVERSITY
|
CA
|
$1,363,549
|
|
Hematology
|
2014
|
NCI
|
5R01CA047148-27
|
|
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
|
MYERS, ANDREW
|
HARVARD UNIVERSITY
|
MA
|
$705,513
|
|
Hematology
|
2014
|
NCI
|
5R01CA097250-11
|
|
ROLE OF BETA 3 INTEGRIN IN SKELETAL METASTASIS
|
WEILBAECHER, KATHERINE
|
WASHINGTON UNIVERSITY
|
MO
|
$349,620
|
|
Hematology
|
2014
|
NCI
|
5R01CA102774-10
|
|
A mouse model for human gastrointestinal stromal tumor
|
BESMER, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$363,278
|
|
Hematology
|
2014
|
NCI
|
5R01CA149668-05
|
|
Targeting apoptosis via chemical design of Bcl-2 antagonists
|
PELLECCHIA, MAURIZIO
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$380,712
|
|
Hematology
|
2014
|
NHLBI
|
5F30HL107092-04
|
|
Phagocyte Intoxication by ExoU in Pseudomonas Pneumonia
|
ZHANG, ANGELICA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$45,418
|
|
Hematology
|
2014
|
NINDS
|
5R01NS062097-05
|
|
Transplantation of Pre-conditioned Bone Marrow Mesenchymal Stem Cells after Ische
|
WEI, LING
|
EMORY UNIVERSITY
|
GA
|
$328,958
|
|
Hematology
|
2014
|
NCI
|
5R01CA153348-05
|
|
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
|
FELIX, CAROLYN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$384,562
|
|
Hematology
|
2014
|
NCI
|
5R01CA167511-02
|
|
Translation of Novel Therapeutic Targets in Multiple Myeloma
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
AZ
|
$418,950
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106186-03
|
|
Molecular Mechanism of Platelet Dense Granule Biogenesis
|
DI PIETRO, SANTIAGO
|
COLORADO STATE UNIVERSITY
|
CO
|
$422,351
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL112633-03
|
|
von Willebrand Factor in Sickle Cell Disease Pathophysiology
|
LOPEZ, JOSE
|
PUGET SOUND BLOOD CENTER
|
WA
|
$731,326
|
|
Hematology
|
2014
|
NHLBI
|
5R21HL113978-02
|
|
The Role of RB Family Proteins in an S Phase-Dependent Erythroid Commitment Step
|
SOCOLOVSKY, MERAV
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$204,575
|
|
Hematology
|
2014
|
NCI
|
5R01CA088763-13
|
|
LANA and Cellular Gene Expression
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
FL
|
$224,007
|
|
Hematology
|
2014
|
NCI
|
5R01CA144248-05
|
|
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$286,022
|
|
Hematology
|
2014
|
NCI
|
5R01CA150547-05
|
|
Targeting Cdc42 in leukemia stem cells
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$298,713
|
|
Hematology
|
2014
|
NCI
|
5R01CA153260-15
|
|
Control of Lineage Commitment in Developing Thymocytes
|
KAPPES, DIETMAR
|
RESEARCH INST OF FOX CHASE CAN CTR
|
PA
|
$435,886
|
|
Hematology
|
2014
|
NCI
|
5R01CA154228-04
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$340,155
|
|
Hematology
|
2014
|
NCI
|
5R01CA166144-03
|
|
Development of Therapeutic CD59 inhibitor for treating B-cell malignancies
|
QIN, XUEBIN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$324,825
|
|
Hematology
|
2014
|
NIGMS
|
2T32GM008516-21
|
|
Training in Trauma and Sepsis Research
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$314,257
|
|
Hematology
|
2014
|
NHLBI
|
1R21HL120791-01
|
|
Identifying Genome-wide Association Study-Nominated Regulators of Erythropoiesis
|
SANKARAN, VIJAY
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$263,125
|
|
Hematology
|
2014
|
NHLBI
|
2T32HL007344-36
|
|
Program in Hematology: Molecular & Cell Biology of Blood Cells
|
LENTZ, STEVEN
|
UNIVERSITY OF IOWA
|
IA
|
$173,622
|
|
Hematology
|
2014
|
NCI
|
5R01CA140963-05
|
|
Cell Cycle Regulation and Adult T Cell Leukemia
|
GIAM, CHOU-ZEN
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$298,713
|
|
Hematology
|
2014
|
NCI
|
5R01CA164605-03
|
|
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
TN
|
$391,041
|
|
Hematology
|
2014
|
NCI
|
5R01CA149707-05
|
|
Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster
|
VENTURA, ANDREA
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$372,707
|
|
Hematology
|
2014
|
NIDDK
|
5R01DK095201-03
|
|
Control of iron absorption by intestinal HIF2 in iron and hematological disorders
|
SHAH, YATRIK
|
UNIVERSITY OF MICHIGAN
|
MI
|
$332,834
|
|
Hematology
|
2014
|
NHLBI
|
5R01HL106029-04
|
|
Effectiveness and Safety of Antithrombotic Strategies after Joint Replacement
|
HYLEK, ELAINE
|
BOSTON MEDICAL CENTER
|
MA
|
$575,918
|
|
Hematology
|
2014
|
NHLBI
|
5F30HL108590-03
|
|
The role of metalloprotease-PAR1 signaling in vascular injury and repair
|
AUSTIN, KARYN
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$38,398
|
|
Hematology
|
2014
|
NHLBI
|
5T32HL110841-03
|
|
Children's Research Institute Hematology Research Training Grant
|
LUBAN, NAOMI
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$296,735
|
|
Hematology
|
2014
|
NHLBI
|
2T32HL007525-31
|
|
Training Program in Hematology
|
BRODSKY, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$255,342
|
|
Hematology
|
2014
|
NHLBI
|
2T32HL007501-32
|
|
Research Training in Blood Diseases and Resources
|
STEINBERG, MARTIN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$222,310
|
|
Hematology
|
2014
|
NIAID
|
5R01AI095575-03
|
|
HTS platform for identification of regulators of cell adhesion molecule signaling
|
WOODSIDE, DARREN
|
TEXAS HEART INSTITUTE
|
TX
|
$382,500
|
|
Hematology
|
2014
|
NHLBI
|
5R34HL107801-03
|
|
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohisti
|
JORDAN, MICHAEL
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$229,500
|
|
Hematology
|
2014
|
NINDS
|
5R21NS080014-02
|
|
Expansion of intracranial hemorrhage by tPA after traumatic brain injury
|
HIGAZI, ABD ALROOF
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$198,000
|
|
Hematology
|
2014
|
NHLBI
|
2T32HL007439-36
|
|
Hematology Clinical Research Training Program
|
BRASS, LAWRENCE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$688,632
|
|
Hematology
|
2014
|
NHLBI
|
2T32HL007899-16
|
|
Research Training In Hematology
|
SHEEHAN, JOHN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$403,714
|
|
Hematology
|
2014
|
NCI
|
5R01CA133571-05
|
|
Coordinately regulated alternative splicing in DNA damage and cancer
|
CHANDLER, DAWN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$289,653
|
|
Hematology
|
2014
|
NCI
|
5R01CA149109-04
|
|
The role of microRNAs in leukemic initiation and maintenance
|
LU, JUN
|
YALE UNIVERSITY
|
CT
|
$335,123
|
|
Hematology
|
2014
|
NCI
|
5R01CA154802-04
|
|
Approaches to discover and quantify apoptotic biomarkers for cancer treatment
|
WELLS, JAMES
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$310,970
|
|
|
